Nicholas Investment Partners, LP - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,116,950
-86.8%
68,905
-86.4%
0.08%
-88.2%
Q1 2023$8,442,716
+110.2%
507,070
+4.8%
0.64%
+74.5%
Q2 2019$4,017,000
-18.3%
483,951
-2.2%
0.37%
-16.2%
Q1 2019$4,918,000
+29.1%
494,730
-0.6%
0.44%
+7.1%
Q4 2018$3,809,000
-62.3%
497,962
-14.1%
0.41%
-49.4%
Q3 2018$10,104,000
+106.0%
580,028
+12.2%
0.81%
+134.8%
Q2 2018$4,904,000516,7910.34%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders